Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effectiveness and safety of Pacritinib in patients with VEXAS syndrome; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vexas Syndrome

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: VEXAS, VEXAS Syndrome | Phase 2 | Status: RECRUITING